New grant to develop cancer diagnosis tool

Share this on social media:

A project to develop a new kind of scanner that could aid cancer diagnosis and treatment has received a £325k grant to help make the new technology available for general use.

The new scanner from Michelson Diagnostics, uses optical coherence tomography to provide high-resolution images of cancerous tissue below the surface of the skin without any incisions, allowing them to make more accurate decisions about where to perform surgery. The invention of this scanner was covered in by imveurope.com in June this year.

Now however, a new collaboration between Michelson Diagnostics, the University of Cardiff, the Gloucestershire Hospitals NHS Foundation Trust and the UK National Physical Laboratory, plans to make the new device generally available for all hospitals. The new project, called Omicron, has been awarded a £325k grant from the UK’s Technology Strategy Board, to support the development.

Recent News

14 September 2020

Messe Stuttgart has set a date of 5 to 7 October 2021 for the Vision show, which was cancelled because of the coronavirus pandemic. The show will be held in parallel with Motek

03 September 2020

Terahertz imaging company, Tihive, has been awarded €8.6m from the European Innovation Council's Accelerator programme to scale up its industrial inspection technology

01 September 2020

The robotics market in North America is down 18 per cent so far compared to the same period last year

13 August 2020

The company said that shifts in demand, particularly in the areas of sports and entertainment, infrastructure and automotive, had a negative impact